Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA 15261, USA.
Biomaterials. 2010 Oct;31(30):7805-12. doi: 10.1016/j.biomaterials.2010.07.010. Epub 2010 Jul 31.
Angiogenesis is an organized series of events, beginning with vessel destabilization, followed by endothelial cell re-organization, and ending with vessel maturation. Vascular endothelial growth factor (VEGF) aids in vascular permeability and endothelial cell recruitment while sphingosine 1-phosphate (S1P) stimulates vascular stability. Accordingly, VEGF may inhibit vessel stabilization while S1P may inhibit endothelial cell recruitment. For this reason, we created a new externally-regulated delivery model that not only permits sustained release of bioactive factors, but also temporal separation of the delivery of growth factors. Using this model, sequential delivery of factors was first confirmed in vitro with associated endothelial cells responding in a dose dependent manner. Furthermore, using a modified murine Matrigel plug model, it is apparent that delivery strategies where VEGF presentation is temporally separated from S1P presentation not only led to greater recruitment of endothelial cells, but also higher maturation index of associated vessels.
血管生成是一个有序的事件系列,始于血管不稳定,接着是内皮细胞的重新组织,最后是血管成熟。血管内皮生长因子(VEGF)有助于血管通透性和内皮细胞募集,而鞘氨醇 1-磷酸(S1P)刺激血管稳定。因此,VEGF 可能抑制血管稳定,而 S1P 可能抑制内皮细胞募集。基于此,我们创建了一种新的外部调节的递药模型,不仅允许生物活性因子的持续释放,而且还可以在时间上分隔生长因子的递药。使用该模型,我们首先在体外证实了因子的顺序递药,相关的内皮细胞以剂量依赖的方式作出反应。此外,使用改良的小鼠 Matrigel plugs 模型,很明显,VEGF 呈现与 S1P 呈现在时间上分离的递药策略不仅导致更多的内皮细胞募集,而且与相关血管的成熟指数更高。